Viewing Study NCT07270835


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2026-01-25 @ 9:42 AM
Study NCT ID: NCT07270835
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2025-11-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophagocytic Lymphohistiocytosis View
None B Cell Lymphoma View
Keywords: